| Financial Parameter | Q4 FY26 | Q4 FY25 | Change |
|---|---|---|---|
| Net Profit | ₹36.26 crore | ₹11.5 crore | ▲ 215% |
| Total Income / Revenue | ₹132.04 crore | ₹61.1 crore | ▲ 116% |
| EBITDA | ₹37.52 crore | ₹13 crore | ▲ 188% |
-
Results Beat Expectations: The company’s performance far exceeded its annual guidance. Cupid had set a revenue target of ₹335 crore and a net profit target of ₹100 crore for the full year, which it has now surpassed by a wide margin .
📈 Full-Year FY26 Point-to-Point Performance
The stellar quarterly performance capped off a remarkable financial year, with the company showing a massive leap in scale and profitability.
| Financial Parameter | FY26 | FY25 | Change |
|---|---|---|---|
| Net Profit | ₹108.2 crore | ₹40.9 crore | ▲ 165% |
| Total Income / Revenue | ₹391.4 crore | ₹203.2 crore | ▲ 93% |
-
Market Cap Milestone: With a market capitalization of approximately ₹17,959 crore, the stock has delivered multibagger returns, rising over 600% in the last year .
🚀 What Drove the Growth? Key Business Segments
Cupid is successfully transforming from a niche player into a diversified FMCG and healthcare company. Here is how its different verticals performed in FY26:
-
Male Condoms (Still the Anchor): This remains the largest revenue contributor, generating ₹181.1 crore. The company is expanding its capacity to 1.25 billion male condoms annually, strengthening its core competency .
-
FMCG Products (The New Engine): The fastest-growing segment, which includes deodorants, perfumes, petroleum jelly, and face wash, contributed ₹84.3 crore in FY26. This demonstrates a successful pivot beyond sexual wellness into daily-use consumer goods .
-
Female Condoms (Global Niche): A significant contributor at ₹60.7 crore. Cupid is developing a new nitrile female condom to target the premium global market, as the global market for this product is projected to exceed $1.2 billion by 2030 .
-
Exports (The Growth Driver): Exports accounted for 59% of total revenue (₹208 crore). The company sells to over 125 countries, and a favorable USD/INR exchange rate is acting as a tailwind for these earnings .
🔮 Future Prospects: What’s Next for Cupid?
The management has laid out a highly ambitious roadmap for FY27 and beyond. Here’s what investors are looking at:
1. Aggressive Financial Targets for FY27
The company has guided for a revenue of ₹600 crore and a net profit of ₹180 crore. This implies a growth of over 50% from the stellar FY26 numbers. Management also expects to maintain a net profit margin above 30% .
2. Strategic Saudi Arabia Expansion (Key Catalyst)
Cupid has approved setting up an FMCG manufacturing facility in Saudi Arabia, targeted for completion by March 2027. This will allow it to serve the high-spending GCC markets more effectively .
3. Massive Distribution Advantage
The company has made a strategic investment of ₹331 crore in Baazar Style Retail (owner of over 260 stores). This provides Cupid with immediate, preferential access to a large retail network, ensuring its new FMCG products get prime shelf space and deep market penetration .
4. Operational Stability & Raw Material Security
The management has secured raw material inventory for over six months, insulating the business from near-term shocks in crude oil derivatives and inflation, ensuring margin stability .
5. R&D and Product Development
-
WHO Approvals Pending: The company is awaiting WHO prequalification for its Malaria IVD kit and its Version 3 Female Condom, which could open up large institutional demand globally .
-
Nitrile Innovation: Developing nitrile-based female condoms to capture a premium, latex-free segment of the market .
💡 Rupie Speak Insight
"Cupid is firing on all cylinders. It is no longer just a 'condom stock'; it is a high-growth FMCG export story with a strong manufacturing edge. The Saudi plant and the retail investment are game-changers for long-term visibility."
-
The Good: Beat all guidance, diversified revenue streams (FMCG), strong export tailwinds, aggressive expansion plans.
-
The Watch-Outs: The stock has run up significantly (600% in 1 year). Execution of the Saudi plant and integration of the retail investment will be key to justifying the high valuation.
Disclaimer: This report is for informational purposes only and does not constitute investment advice. Stock markets are subject to risks. Please consult your financial advisor before making any trading decisions. The views expressed are based on public data and are not a recommendation to buy or sell the stock.
